PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-09-19

Date Title Company
19-Sep-2025 BioNxt Solutions Announces Closing of Shares for Debt Settlement ACCESS Newswire
19-Sep-2025 aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year aap Implantate AG
19-Sep-2025 Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals ACCESS Newswire
19-Sep-2025 Advicenne Reports First Half Financial Results as of June 30, 2025, and Updates on Its Activities Businesswire
19-Sep-2025 Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies ACCESS Newswire
19-Sep-2025 JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program Businesswire
19-Sep-2025 Candid Therapeutics Recognized as a 2025 Endpoints 11 Honoree Businesswire
19-Sep-2025 Shibuya Hoppmann Highlights FS-70 Scallop Centrifugal Feeder for High-Performance Packaging Applications Shibuya Hoppmann
19-Sep-2025 No Difference in Transplant Outcomes Seen for Patients Unlikely to Find a Matched Unrelated Donor When a Donor Search Prognosis Strategy is Used Businesswire
19-Sep-2025 xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery Businesswire
19-Sep-2025 Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories ACCESS Newswire
19-Sep-2025 Asia-Pacific Robotic Neurosurgery Research and Forecast Report 2025-2035 | Rapid Expansion Fueled by Healthcare Infrastructure Throughout Emerging APAC Markets - ResearchAndMarkets.com Businesswire
19-Sep-2025 Celltrion announces commercial availability of Omlyclo™ across Europe at EADV 2025 Celltrion
19-Sep-2025 United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis Businesswire
19-Sep-2025 KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema Businesswire
19-Sep-2025 Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season Businesswire
19-Sep-2025 Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer Businesswire
19-Sep-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
19-Sep-2025 Biotest AG: Extraordinary general meeting convened at the request of Grifols S.A. Biotest AG
19-Sep-2025 European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively Businesswire